Nooro's Pain Relief Promise: FDA Claims, Science, and Consumer Warnings

DOVER, DE – March 06, 2026 – In an era where consumers are increasingly seeking non-pharmaceutical solutions for chronic pain, the market for at-home wellness devices has exploded. Among the most visible is the Nooro NMES Foot Massager, a product aggressively marketed across social media as a revolutionary tool for relieving neuropathic pain and improving circulation. However, a closer examination of the device's regulatory status, the science behind its technology, and the company's business practices reveals a complex picture that every potential customer should understand.

The device is positioned as a modern solution for an age-old problem, tapping into a significant demand for accessible pain management. But beneath the polished marketing and glowing testimonials lies a trail of consumer complaints and important distinctions between scientific principles and product-specific proof.

The 'FDA Cleared' Distinction

Central to Nooro's marketing is the prominent claim that its foot massager is an "FDA Cleared Class II Medical Device." This language is a powerful trust signal for consumers, but its meaning is widely misunderstood. Research confirms the device, identified as the "Sumsens TENS & PMS, model SM9187," received 510(k) clearance from the U.S. Food and Drug Administration in 2019. This clearance, K192248, was granted to its manufacturer, Hangzhou Aiqing Technology Co., Ltd., based in China.

However, FDA clearance is not FDA approval. The 510(k) clearance process simply means the FDA has determined a device is "substantially equivalent" in safety and intended use to a legally marketed predicate device already on the market. In this case, the device was cleared for the general uses of a Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief and a Powered Muscle Stimulator (PMS) for muscle conditioning. It does not mean the FDA has independently validated Nooro's specific advertising claims about reversing neuropathy, restoring nerve function, or guaranteeing pain relief for every user.

This regulatory nuance is critical. While the device meets the safety and performance standards for its category, the FDA clearance does not serve as an endorsement of the dramatic therapeutic outcomes featured on Nooro's sales page. Consumers are left to navigate the gap between a general safety clearance and specific marketing promises.

NMES, TENS, and the Science of Stimulation

Nooro's marketing consistently refers to its core technology as "NMES" (NeuroMuscular Electrical Stimulation). Yet, the product's official FDA clearance identifies it as a "TENS & PMS" unit. While related, these are technically different modalities. TENS primarily targets sensory nerves to block pain signals, while NMES and PMS (Powered Muscle Stimulation) are designed to cause involuntary muscle contractions to improve muscle function and circulation.

The core technology of NMES does have a legitimate, research-backed history in clinical rehabilitation settings for applications like preventing muscle atrophy and improving blood flow. The problem for consumers arises when this general, technology-level research is presented as evidence for a specific commercial product. There are no publicly available, peer-reviewed clinical trials that have evaluated the Nooro NMES Foot Massager itself to prove it delivers the same outcomes seen in controlled clinical studies.

This evidence gap is further complicated by the use of professional endorsements. The company's website prominently features Dr. Jeremy Campbell, a Doctor of Physical Therapy, who advocates for the device's benefits. While his credentials appear legitimate, his role is primarily promotional. There is no evidence of him or the mysterious "Dr. Anthony" also mentioned in marketing materials having conducted or published independent, peer-reviewed research on this specific product. Their endorsements appear to be based on the general principles of electrotherapy, not on a scientific validation of the Nooro device.

The Consumer Experience: Promises vs. Problems

Beyond the regulatory and scientific nuances, the real-world consumer experience paints a troubling picture. Nooro's parent company, XF Agencija US Inc., currently holds an "F" rating from the Better Business Bureau (BBB). The BBB page is filled with a pattern of complaints alleging that the product fails to perform as advertised, along with significant issues regarding the company's customer service and refund process.

While Nooro advertises a "90-day money-back guarantee," consumers report that the process is fraught with difficulty. The company's policy requires customers to pay for return shipping, which can be costly. Many complaints describe unresponsive customer service, lengthy delays, and a frustrating, bureaucratic process to secure a refund. Furthermore, the guarantee does not apply to subscription products, which some customers report being signed up for unknowingly during the checkout process.

Independent review sites like Trustpilot echo these concerns, presenting a mix of glowing five-star reviews and a significant volume of one-star complaints. The negative reviews frequently cite the device's lack of effectiveness for their condition, poor durability, and the same customer service and refund nightmares detailed on the BBB. This stark contrast between the company's claim of "over 100,000 happy customers" and the public record of dissatisfaction suggests a significant disconnect.

Behind the Brand: A Global Direct-to-Consumer Model

The structure of the company behind Nooro is typical of many modern e-commerce brands. XF Agencija US Inc. is a registered corporation in Delaware with an office address in Hong Kong, but it functions primarily as a digital marketing and sales entity. The physical product is sourced from an established Chinese manufacturer, Hangzhou Aiqing Technology Co., Ltd., which specializes in producing TENS and EMS devices for numerous brands worldwide.

This model allows for rapid scaling and aggressive direct-to-consumer advertising, but it can also create challenges in quality control and customer support. When issues arise, consumers find themselves dealing with a digital storefront, not a brick-and-mortar company, making it difficult to resolve disputes over product performance or refunds.

Ultimately, consumers considering the Nooro NMES Foot Massager are faced with a product that sits at the intersection of promising technology, aggressive marketing, and questionable business practices. The underlying science of electrical stimulation is real, but the translation of that science into a specific, effective, and reliable consumer product backed by transparent customer service remains a critical question that each buyer must weigh carefully before making a purchase.